An open randomized trial comparing disulfiram and naltrexone in adolescents with alcohol dependence

References

• Anton R. F., Moak D. H., Latham P. K., Waid L. R., Malcolm D. J., Dias J. K., Roberts J. S. Post treatment results of combining naltrexone and cognitive behavioral therapy for the treatment of alcoholism. Journal of Clinical Psychopharmacology 2001; 21: 72–77
   PubMed Web of Science ®Google Scholar
• Anton R. F., Moak D. H., Waid L. R., Latham P. K., Malcolm R. J., Dias J. K. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo controlled trial. American Journal of Psychiatry 1999; 156: 1758–1764
   PubMed Web of Science ®Google Scholar
• Anton R. F., Swift R. M. Current pharmacotherapies for alcoholism: a US perspective. American Journal of Addiction 2003; 12: S53–S68
   Web of Science ®Google Scholar
• Benjamin R., Grant E. R., Pohorecky L. A. Naltrexone reverses ethanol induced dopamine release in the nucleus accumbens in awake freely moving rats. Brain Research 1993; 621: 137–140
   PubMed Web of Science ®Google Scholar
• Berglund M., Thelander S., Jonsson E. Treating Alcohol & Drug Abuse—an evidence based review. 2003, Wiley VCH, Verlag GmBH and Co, Weinheim
   Google Scholar
• Brewer C. Recent developments in Disulfiram treatment. Alcohol & Alcoholism 1995; 28: 385–393
   Google Scholar
• Brewer C. Patterns of compliance and evasion in treatment programs that include supervised Disulfiram. Alcohol & Alcoholism 1986; 21: 385–388
   PubMed Web of Science ®Google Scholar
• Campbell M., Schopler E., Cueva J. E., Hallin A. Treatment of autistic disorder. Journal of the American Academy of Child & Adolescent Psychiatry 1996; 35: 134–143
   PubMed Web of Science ®Google Scholar
• Deas D., May K., Randall C. L., Johnson N. A., Anton R. F. Naltrexone treatment of adolescent alcoholics: an open label pilot study. Journal of Child & Adolescent Psychopharmacology 2005; 15: 723–728
   PubMed Web of Science ®Google Scholar
• Deas D., Randall C. L., Roberts R. S., Anton R. F. A double blind placebo controlled trial of sertraline in depressed adolescent alcoholics: a pilot study. Human Psychopharmacology Clinical & Experimental 2000; 15: 461–469
   PubMed Web of Science ®Google Scholar
• Deas D., Roberts J., Randall C., Anton R. F. The adolescent obsessive compulsive drinking scale (A‐OCDS): a measure of drinking thoughts and urges in adolescents/young adults. Journal of the National Medical Association 2001; 93((3))92–103
   Google Scholar
• DeSousa A., DeSousa A. A one year pragmatic trial of naltrexone versus disulfiram in the treatment of alcohol dependence. Alcohol & Alcoholism 2004; 39: 528–531
   Google Scholar
• DeSousa A., DeSousa A. An open randomized study of disulfiram and acamprosate in the long term management of alcoholism. Alcohol & Alcoholism 2005; 40: 545–548
   Google Scholar
• Fuller R. K., Gordis F. Does disulfiram have a role in alcoholism treatment today?. Addiction 2004; 99: 21–24
   PubMed Web of Science ®Google Scholar
• Geller B., Cooper T. B., Sun K., Zimmerman B., Fraizer J., Williams M., Heath J. Double blind and placebo controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. Journal of the American Academy of Child & Adolescent Psychiatry 1998; 37: 171–178
   PubMed Web of Science ®Google Scholar
• Johnston L. D., O'Malley P. M., Bachman J. G., Schulenberg J. E. Monitoring the Future National Results on Adolescent Drug Use: overview of the key findings. National Institute on Drug Abuse, Bethesda 2005
   Google Scholar
• Kaufman J., Birhamer B., Brent D., Rao U., Ryan N. Kiddie‐SADS‐Present and Lifetime Version. 1996, (K‐SADS‐PL)
   Google Scholar
• Lifrak P. D., Alterman A. I., O'Brien C. P., Volpicelli J. R. Naltrexone for adolescent alcoholics. American Journal of Psychiatry 1997; 154: 439–440
   PubMed Web of Science ®Google Scholar
• O'Malley S. S., Caroll K. M. Psychotherapeutic considerations in pharmacological trials. Alcohol Clinical & Experimental Research 1996; 20: 17A–22A
   Google Scholar
• O'Malley S. S., Jaffe A. J., Chang G., Schottenfeld R. S., Meyer R. E., Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Archives of General Psychiatry 1992; 49((11))881–887
   PubMed Web of Science ®Google Scholar
• Savas M. C., Gullu J. H. Disulfiram ethanol reaction—the significance of supervision. Annals of Pharmacotherapy 1997; 31: 374–375
   PubMed Web of Science ®Google Scholar
• Sobell L. C., Sobell M. B., Leo G. I., Cancilla A. Reliability of a timeline method : assessing normal drinker's report of recent drinking and a comparative evaluation across several populations. British Journal of Addiction 1988; 83: 393–402
   PubMedGoogle Scholar
• Suh J. J., Pettinati H. M., Kampman K. M., O'Brien C. P. The status of disulfiram—half a century later. Journal of Clinical Psychopharmacology 2006; 26: 290–302
   PubMed Web of Science ®Google Scholar
• Swift R. M. Drug therapy for alcohol dependence. New England Journal of Medicine 1999; 340: 1482–1490
   PubMed Web of Science ®Google Scholar
• Tarter R. E., Moss H. B., Vanyukov M. Research designs for family studies. Drug Abuse Prevention, W Bukoski, Z Anzel. Greenwood Publishing Group. 1996
   Google Scholar
• Volpicelli J. R., Alterman A. I., Havashida M., O'Brien C. P. Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry 1992; 49((11))876–880
   PubMed Web of Science ®Google Scholar
• Wold M., Kaminer Y. Naltrexone for alcohol abuse [letter]. Journal of the American Academy of Child & Adolescent Psychiatry 1997; 36: 6–7
   PubMed Web of Science ®Google Scholar